GlaxoSmithKline gets order for 60m swine flu vaccines from the UK

GlaxoSmithKline, the UK’s largest pharmaceutical company, has received an order for 60m swine flu vaccines from the UK Government.

The company, which already manufactures one of the key anti-viral treatments for the virus, Relenza, has also received millions of orders from other European governments including France.

Salon 1999 - Consider this: The British and French medical establishments have already rejected Relenza as an essentially worthless drug.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA